Skip to main content
Super Sales India Ltd. logo

Super Sales India Ltd. — Investor Relations & Filings

Ticker · 512527 ISIN · INE091C01017 LEI · 3358005XKLUH6GKCEK18 BSE.NS Manufacturing
Filings indexed 556 across all filing types
Latest filing 2020-10-08 Regulatory Filings
Country IN India
Listing BSE.NS 512527

About Super Sales India Ltd.

https://www.supersales.co.in/

Super Sales India Ltd. operates through three primary divisions: Textile, Agency, and Engineering. The Textile division specializes in the manufacturing of cotton yarn and grey fabrics, utilizing advanced spinning technologies. The Agency division functions as a marketing and service provider for textile machinery, maintaining a long-standing partnership with Lakshmi Machine Works Limited to facilitate equipment sales and technical support. The Engineering division manages a foundry focused on the production of high-grade iron castings for diverse industrial components. The company integrates manufacturing excellence with specialized marketing services, focusing on technical reliability and quality standards across its product portfolio.

Recent filings

Filing Released Lang Actions
certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th sep,2020
Regulatory Filings
2020-10-08 English
Publication of Board Meeting Notice
Regulatory Filings
2020-10-07 English
SUPER SALES INDIA LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2020 ,inter alia, to consider and approve Unaudited Financial Results ....
Regulatory Filings
2020-09-30 English
Closure of Trading Window
Regulatory Filings
2020-09-30 English
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the ....
Regulatory Filings Classification · 95% confidence The document is a letter responding to a stock exchange query about unusual price movement of the company's shares. It references the publication date of the company's 1st quarter results but does not contain any financial data or detailed report itself. The letter clarifies that no undisclosed information is pending and that all regulatory filings have been made. The document is short (1220 characters) and serves as a regulatory communication to the exchange rather than a financial report or announcement of a meeting or vote. Therefore, it fits best under Regulatory Filings (RNS) as a compliance-related disclosure.
2020-08-12 English
Impact of COVID-19 lockdown and restrictions
Regulatory Filings
2020-08-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.